Tumor Necrosis Factor-α Production by Alveolar Macrophages During the Early Development of Phosgene-Induced Lung Injury

References

• Beutler B., Krochin N., Milsark I. W., Luedke C., Cerami A. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 1986; 232: 977–980
   PubMed Web of Science ®Google Scholar
• Brigham K. L., Bowers R. E., McKeen C. R. Methylprednisolone prevention of increased lung vascular permeability following endotoxemia in sheep. J. Clin. Invest. 1981; 67: 1103–1110
   PubMed Web of Science ®Google Scholar
• Chang S. W., Sakai A., Voelkel N. F. Dibutyryl cAMP blocks endotoxin-induced lung injury in rats. Am. Rev. Respir. Dis. 1989; 140: 1814–1817
   PubMedGoogle Scholar
• Currie W. D., Hatch G. E., Frosolono M. F. Changes in lung ATP concentration in the rat after low-level phosgene exposure. J. Biochem. Toxicol. 1987; 2: 105–114
   PubMedGoogle Scholar
• Diller W. F. Pathogenesis of phosgene poisoning. Toxicol. Ind. Health 1985; 1: 7–15
   PubMedGoogle Scholar
• Diller W. F., Bruch J., Dehner W. Pulmonary changes in the rat following low phosgene exposure. Arch. Toxicol. 1985; 57: 184–190
   PubMed Web of Science ®Google Scholar
• Ehrlich J. P., Burleson G. R. Enhanced and prolonged pulmonary influenza virus infection following phosgene inhalation. J. Toxicol. Environ. Health 1991; 34: 259–273
   PubMed Web of Science ®Google Scholar
• Eichacker P. Q., Hoffman W. D., Farese A., Banks S. M., Kuo G. C., MacVitte T. J., Natanson C. TNF, but not IL-1 in dogs causes lethal lung injury and multiple organ dysfunction similar to human sepsis. J. Appl. Physiol. 1991; 71: 1979–1989
   PubMed Web of Science ®Google Scholar
• Everett E. D., Overholt E. L. Phosgene poisoning. J. Am. Med. Assoc. 1968; 205: 103–105
   PubMed Web of Science ®Google Scholar
• Flick D. A., Gifford G. E. Comparison of in vitro cell cytotoxicity assays for tumor necrosis factor. J. Immunol. Methods 1984; 68: 167–175
   PubMed Web of Science ®Google Scholar
• Flick D. A., Gonzalez-Rothi R. J., Harris J. O., Gifford G. E. Rat lung macrophage tumor cytotoxin production: Impairment by chronic in vivo cigarette smoke exposure. Cancer Res. 1985; 45: 5225–5229
   PubMed Web of Science ®Google Scholar
• Foy T., Marrion J., Brigham K. L., Harris T. R. Isoproterenol and aminophylline reduce lung capillary filtration during high permeability. J. Appl. Physiol. 1979; 46: 146–151
   PubMed Web of Science ®Google Scholar
• Frosolono M. F., Currie W. D. Response of pulmonary surfactant system to phosgene. Toxicol. Ind. Health 1985; 1: 29–35
   PubMedGoogle Scholar
• Gilchrist H. L., Matz P. B. The residual effects of warfare gases: The use of chlorine gas, with report of cases. Med. Bull. VA 1933; 9: 229–270
   Google Scholar
• Guo Y-L, Kennedy T. P., Michael J. R., Sciuto M. A., Chio A. J., Adkinson F. N., Jr., Gurtner C. H. Mechanism of phosgene-induced lung toxicity: Role of arachidonate mediators. J. Appl. Physiol. 1990; 69(5)1615–1622
   PubMed Web of Science ®Google Scholar
• Curley L. R., Valdez J. G., London J. E., Spall D. A., Dethloff L. A., Lehnert B. E. An HPLC procedure for the analysis of proteins in lung lavage fluid. Anal. Biochem. 1988; 172: 465–478
   PubMed Web of Science ®Google Scholar
• Kennedy T. P., Michael J. R., Hoidal J. R., Hasty D., Sciuto A. M., Hopkins C., Lazar R., Bysami G. K., Tolley E., Gurtner G. H. Dibutyryl cAMP, aminophylline, and β adrenergic agonists protect against pulmonary edema caused by phosgene. J. Appl. Physiol. 1989; 67(6)2542–2552
   PubMed Web of Science ®Google Scholar
• Kennedy T. P., Rao N. V., Noah W., Jafri M. H., Jr., Michael J. R., Gurtner G. H., Hoidal J. R. Ibuprofen prevents oxidant lung injury and in vitro lipid peroxidation by chelating iron. J. Clin. Invest. 1990; 86: 1565–1573
   PubMed Web of Science ®Google Scholar
• Koyama S., Toyofuku T., Hirai K., Yoshimura K., Sakai A., Kobayashi T. Dibutyryl cyclic AMP attenuates lung responses induced by endotoxin in conscious sheep. Am. Rev. Respir. Dis. 1992; 146: 32–38
   PubMedGoogle Scholar
• Lehnert B. E., Archuleta D. A., Behr M. J., Stavert D. M. Lung injury after acute inhalation of perfluoroisobutylene: Exposure concentration-response relationships. Inhal. Toxicol. 1993; 5: 1–32
   Web of Science ®Google Scholar
• Millar A. B., Singer M., Meager A., Foley N. M., Johnson N. I., Rook G. A. W. Tumour necrosis factor in bronchoalveolar secretions of patients with adult respiratory distress syndrome. Lancet 1989; ii: 712–714
   Google Scholar
• National Institute for Occupational Safety and Health. Criteria for a recommended standard: Occupational exposure to phosgene. U.S. Department of Health, Education, and Welfare, U.S. Government Printing Office, Washington, DC 1976; 76–137, Publication No. 76–137
   Google Scholar
• Okusawa S., Gelfand J. A., Ikejima T., Conolly R. J., Dinarello C. A. Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J. Clin. Invest. 1988; 81(4)1162–1172
   PubMed Web of Science ®Google Scholar
• Pawlowski R., Frosolono M. F. Effect of phosgene on rat lungs after single high-level exposure. II. Ultrastructural alterations. Arch. Environ. Health 1977; 32(6)278–283
   PubMed Web of Science ®Google Scholar
• Pendino K. J., Shuler R. L., Laskin J. D., Laskin D. L. Enhanced production of interleukin-1, tumor necrosis factor-alpha, and fibronectin by rat lung phagocytes following inhalation of a pulmonary irritant. Am. J. Respir. Cell Mol. Biol. 1994; 11: 279–286
   PubMed Web of Science ®Google Scholar
• Polzer G., Linf I., Mosbach M., Schmidt A., Seidel A. Combined influence of quartz dust, ozone, and NO2 on chemotactic mobility, release of chemotactic factors and other cytokines by macrophages in vitro. Toxicol. Lett. 1994; 72: 307–315
   PubMed Web of Science ®Google Scholar
• Remick D. G., Strieter R. M., Lynch J. P., III, Nguyen D., Eskandari M., Kunkel S. L. In vivo dynamics of murine tumor necrosis factor-alpha gene expression. Kinetics of dexamethasone-induced suppression. Lab. Invest. 1989; 60(61)766–771
   PubMedGoogle Scholar
• Snedecor G. W., Cochran W. G. The comparisons of two samples. Statistical methods. Iowa State University Press, Ames 1969a; 91–119
   Google Scholar
• Snedecor G. W., Cochran W. G. Shortcut and non-parametric methods. Statistical methods. Iowa State University Press, Ames 1969b; 120–134
   Google Scholar
• Stephens K. E., Ishisaka A., Larrick J. W., Raffin T. A. Tumor necrosis factor causes incresed pulmonary permeability and edema. Am. Rev. Respir. Dis. 1988; 137: 1364–1370
   PubMed Web of Science ®Google Scholar
• Strieter R. M., Remick D. G., Lynch J. P., III, Genord M., Raiford C., Spengler R., Kunkel S. L. Differential regulation of tumor necrosis factor-alpha in human alveolar macrophages and peripheral blood monocytes: A cellular and molecular analysis. Am. J. Respir. Cell. Mol. Biol. 1989; 1(1)57–63
   PubMed Web of Science ®Google Scholar
• Welbourn C. R. B., Young Y. Endotoxin, septic shock and acute lung injury: neutrophils, macrophages and inflammatory mediators. Br. J. Surg. 1992; 79: 988–1003
   PubMed Web of Science ®Google Scholar
• Zheng H., Crowley J. J., Chan J. C., Hoffmann H., Hatherill J. R., Ishisaka A., Raffin T. A. Attenuation of tumor necrosis factor induced endothelial cell cytotoxicity and neutrophil chemiluminiscence. Am. Rev. Respir. Dis. 1990; 142(51)1073–1078
   PubMedGoogle Scholar